02/04/2019 22:32:06

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MHLD, AVP, DPLO and ARA

NEW YORK, April 02, 2019 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.        

Maiden Holdings, Ltd. (NASDAQGS: MHLD)

Class Period: March 4, 2014 to November 9, 2018

Lead Plaintiff Deadline: April 12, 2019

The complaint alleges that during the Class Period, defendants misrepresented the quality and nature of Maiden’s underwriting and risk management policies and practices and the risks of its reinsurance portfolio. In particular, defendants misleadingly claimed that they were subjecting AmTrust’s insurance portfolio to robust analysis and cross-checks to ensure that the Company had appropriately priced the risk of reinsuring AmTrust’s insurance portfolio. In truth, the Company had failed to employ sufficient underwriting and risk management protocols and had largely abdicated its responsibility to ensure that its AmTrust Reinsurance segment priced policies commensurate with the risk assumed by the Company.

Get additional information about the MHLD lawsuit: https://www.kleinstocklaw.com/pslra-1/maiden-holdings-ltd-loss-submission-form?wire=3

Avon Products, Inc. (NYSE: AVP)

Class Period: August 2, 2016 to August 2, 2017

Lead Plaintiff Deadline: April 15, 2019

In order to inflate its reported revenue and representative growth metric during the Class Period, Avon engaged in an undisclosed scheme whereby it significantly loosened its credit terms in order to recruit new representatives in Brazil, its largest market. Avon did not disclose the changes to its credit terms in Brazil. Avon also failed to increase its allowance for doubtful accounts to account for the changes to its credit terms in Brazil.

Get additional information about the AVP lawsuit: https://www.kleinstocklaw.com/pslra-1/avon-products-inc-loss-submission-form?wire=3

Diplomat Pharmacy, Inc. (NYSE: DPLO)

Class Period: February 26, 2018 to February 21, 2019

Lead Plaintiff Deadline: April 25, 2019

During the class period, Diplomat Pharmacy, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Diplomat had downplayed its success in integrating and growing its PBM business, which included LDI Integrated and National Pharmaceutical, two companies Diplomat had acquired in late 2017; (2) consequently, Diplomat would need to record a non-cash impairment charge upwards of approximately $630 million relating to its PBM business and these 2017 acquisitions; (3) due to the foregoing, Diplomat would withdraw its preliminary 2019 full-year outlook issued less than seven weeks prior; and (4) as a result, defendants’ statements about Diplomat’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Get additional information about the DPLO lawsuit: https://www.kleinstocklaw.com/pslra-1/diplomat-pharmacy-inc-loss-submission-form?wire=3

American Renal Associates Holdings, Inc. (NYSE: ARA)

Class Period: August 10, 2016 to March 27, 2019

Lead Plaintiff Deadline: May 28, 2019

The lawsuit alleges that throughout the class period, American Renal Associates Holdings, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) issues with American Renal’s accounting process for revenue recognition, collections, and related matters would give rise to a U.S. Securities and Exchange Commission (“SEC”) investigation into the same, and increased regulatory scrutiny by the SEC; (2) financial statements for the fiscal years 2014, 2015, 2016 and 2017 contained in its Annual Reports for the years ended December 31, 2016 and 2017, and its condensed consolidated financial statements in quarterly reports from 2016 through 2018, were false and could not be relied upon; (3) American Renal had material weaknesses in its internal control over financial reporting; and (4) as a result, defendants’ public statements were materially false and misleading at all relevant times.

Get additional information about the ARA lawsuit: https://www.kleinstocklaw.com/pslra-1/american-renal-associates-holdings-inc-loss-submission-form?wire=3

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

J. Klein, Esq.

Empire State Building

350 Fifth Avenue

59th Floor

New York, NY 10118

jk@kleinstocklaw.com

Telephone: (212) 616-4899

Fax: (347) 558-9665

www.kleinstocklaw.com

Klein NEW logo black transparent.png

Related content
15 Aug - 
Shareholder Investigation Alert: Halper Sadeh LLP is In..
15 Aug - 
Bragar Eagel & Squire is Investigating Certain Officers..
06 Aug - 
NYSE: ARA Investor Notice: Lawsuit against American Ren..
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Regulatory news

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Photo Release -- WSFS Bank Welcomes Corynn Ciber in Newly Created Role, Chief Digital Officer
2
Euronet Worldwide’s Digital Integrated Payments Cloud powers Sri Lanka’s first QR code-based payment app
3
Rigrodsky & Long, P.A. Files Class Action Suit Against PCM, Inc.
4
Rigrodsky & Long, P.A. Files Class Action Suit Against WageWorks, Inc.
5
Start of Day Message

Related stock quotes

Avon Products Inc 4.180 0.5% Stock price increasing
Diplomat Pharmacy Inc 5.720 7.5% Stock price increasing
Maiden Holdings Ltd 0.4703 -5.9% Stock price decreasing
American Renal Associate.. 6.960 -2.5% Stock price decreasing

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
20 August 2019 11:41:01
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190819.1 - EUROWEB1 - 2019-08-20 12:41:01 - 2019-08-20 11:41:01 - 1000 - Website: OKAY